[{"data":1,"prerenderedAt":24},["ShallowReactive",2],{"$ff8nPxWXIyWb0K-Wprr3t0LS9p_pSIQaVxTLOfNzwfC0":3},{"card":4,"examId":6,"chapterTitle":21,"prev":22,"next":23},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":12,"explanation":13,"explanationDetail":14,"mistakeHint":15,"lectureRef":15,"storyRef":15,"chapterSlug":16,"sectionCode":17,"sectionTitle":18,"clusterSlug":19,"term":15,"sequenceOrder":15,"regionWeight":15,"revisionMark":15,"isActive":20},"ch5-047","touhan","副作用報告様式について、記入欄すべてへの記入がなされる必要がある。",1,[10,11],"正しい","誤り","ox","報告様式のすべての記入欄を埋める必要はありません。購入者等から把握できる範囲で報告すれば十分です。","複数の専門家が関わっている場合も、その薬局・販売業で販売された医薬品の副作用に直接接した専門家1名から報告書が提出されれば十分とされています。",null,"chapter-5","5-II-2","副作用情報等の評価及び措置","fukusayou-hyouka",true,"第5章 医薬品の適正使用・安全対策","ch5-046","ch5-048",1784619074271]